Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Nautilus Biotechnology (NASDAQ: NAUT), a company focused on single molecule protein analysis platforms, has scheduled its Q4 and full year 2024 financial results announcement for February 27, 2025, before market open. The company will host a conference call and webcast at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time on the same day to discuss results, business developments, and outlook. Investors can access the live audio webcast through the company's website.
Nautilus Biotechnology (NASDAQ: NAUT), un'azienda focalizzata sulle piattaforme di analisi proteica a singola molecola, ha programmato l'annuncio dei risultati finanziari per il Q4 e l'intero anno 2024 per il 27 febbraio 2025, prima dell'apertura del mercato. L'azienda ospiterà una conferenza telefonica e un webcast alle 5:30 ora del Pacifico / 8:30 ora dell'Est nello stesso giorno per discutere i risultati, gli sviluppi aziendali e le prospettive. Gli investitori possono accedere al webcast audio in diretta attraverso il sito web dell'azienda.
Nautilus Biotechnology (NASDAQ: NAUT), una empresa enfocada en plataformas de análisis de proteínas de molécula única, ha programado el anuncio de sus resultados financieros para el Q4 y el año completo 2024 para el 27 de febrero de 2025, antes de la apertura del mercado. La empresa llevará a cabo una llamada de conferencia y un webcast a las 5:30 a.m. hora del Pacífico / 8:30 a.m. hora del Este el mismo día para discutir los resultados, los desarrollos comerciales y las perspectivas. Los inversores pueden acceder al webcast de audio en vivo a través del sitio web de la empresa.
나우틸러스 바이오테크놀로지 (NASDAQ: NAUT)는 단일 분자 단백질 분석 플랫폼에 중점을 둔 회사로, 2024년 4분기 및 연간 재무 실적 발표를 2025년 2월 27일에 시장 개장 전에 실시할 예정입니다. 이 회사는 같은 날 태평양 표준시 기준 오전 5시 30분 / 동부 표준시 기준 오전 8시 30분에 결과, 사업 개발 및 전망에 대해 논의하기 위해 컨퍼런스 콜과 웹캐스트를 진행할 것입니다. 투자자들은 회사 웹사이트를 통해 실시간 오디오 웹캐스트에 접근할 수 있습니다.
Nautilus Biotechnology (NASDAQ: NAUT), une entreprise axée sur les plateformes d'analyse de protéines à molécule unique, a prévu d'annoncer ses résultats financiers pour le Q4 et l'année complète 2024 le 27 février 2025, avant l'ouverture des marchés. L'entreprise organisera une conférence téléphonique et un webcast à 5h30, heure du Pacifique / 8h30, heure de l'Est, le même jour pour discuter des résultats, des développements commerciaux et des perspectives. Les investisseurs peuvent accéder au webcast audio en direct via le site Web de l'entreprise.
Nautilus Biotechnology (NASDAQ: NAUT), ein Unternehmen, das sich auf Plattformen zur Analyse einzelner Molekül-Proteine konzentriert, hat die Bekanntgabe seiner finanziellen Ergebnisse für Q4 und das gesamte Jahr 2024 für den 27. Februar 2025 vor Markteröffnung geplant. Das Unternehmen wird am selben Tag um 5:30 Uhr Pazifischer Zeit / 8:30 Uhr Ostzeit eine Telefonkonferenz und ein Webcast abhalten, um Ergebnisse, Geschäftsentwicklungen und Ausblicke zu besprechen. Investoren können über die Unternehmenswebsite auf den Live-Audio-Webcast zugreifen.
- None.
- None.
SEATTLE, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule protein analysis platform, today announced it will report financial results for the fourth quarter and full year of 2024 before market open on Thursday, February 27, 2025.
The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
FAQ
When will Nautilus Biotechnology (NAUT) release Q4 2024 earnings?
What time is the NAUT Q4 2024 earnings call?
Where can I listen to Nautilus Biotechnology's Q4 2024 earnings call?
What will be discussed in NAUT's February 27 earnings call?
